Oxipit is a pioneering medical imaging company specializing in AI-driven solutions that enhance radiology workflows and diagnostic accuracy. Founded in 2017, Oxipit has developed a suite of clinically validated and certified AI tools designed to address the global shortage of radiologists and improve patient care. Their flagship product, ChestLink, is the world's first autonomous AI system capable of identifying normal chest X-rays with 99.9% precision, automating up to 40% of cases and allowing radiologists to focus on more complex studies. Key Features and Functionality: - ChestLink: Autonomously analyzes chest X-rays, generating reports for normal studies without radiologist intervention, thereby reducing workload and enhancing efficiency. - ChestEye: Provides real-time triage by detecting over 30 radiological findings, including pneumothorax and lung nodules, prioritizing critical cases for immediate attention. - CT Eye and MSK Eye: Expanding beyond chest X-rays, these solutions assist in chest CT and musculoskeletal X-ray analysis, identifying conditions such as pulmonary embolism and fractures, and integrating seamlessly into existing radiology workflows. - Oxipit Quality: Acts as a virtual assistant by reviewing medical images and corresponding radiologist reports, instantly notifying radiologists of any missed findings to prevent diagnostic errors. Primary Value and User Benefits: Oxipit's AI solutions significantly alleviate the burden on radiologists by automating routine tasks, allowing them to concentrate on complex cases. This not only enhances diagnostic accuracy but also improves patient outcomes by reducing the time to diagnosis and treatment. By integrating seamlessly into existing systems, Oxipit's tools ensure a smooth transition to AI-assisted workflows, fostering greater efficiency and reliability in medical imaging practices.